Heartflow HTFL
$46.69 +$2.06 (+4.62%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.69 0.00%
Open$43.87
Prev close$44.63
Day range$43.78 – $47.16
Volume1.89M
Market cap$4.10B
P/E (TTM)–
Dividend yield–
HTFL Stock News
Headlines matching Heartflow or the HTFL ticker, most recent first.
- CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Raises Target Price to $56 Positive
- William Blair Maintains Heartflow(HTFL.US) With Buy Rating
- A Quick Look at Today's Ratings for Heartflow(HTFL.US), With a Forecast Between $35 to $45
- Wells Fargo Remains a Buy on HeartFlow, Inc. (HTFL)
- A Quick Look at Today's Ratings for Heartflow(HTFL.US), With a Forecast Between $39 to $45
- Morgan Stanley Remains a Hold on HeartFlow, Inc. (HTFL)
- HeartFlow, Inc. (HTFL) Receives a Buy From J.P. Morgan
- Earnings Flash (HTFL) Heartflow, Inc. Posts Q2 Adjusted Loss $0.07 per Share, Vs. FactSet Est of $-0.13 Negative
- Analysts Offer Insights on NA Companies: HeartFlow, Inc. (HTFL), SanDisk Corp (SNDK) and Waterbridge Infrastructure LLC Class A (WBI)
- Baird Initiates Heartflow(HTFL.US) With Buy Rating, Announces Target Price $34
- Analysts Conflicted on These NA Names: HeartFlow, Inc. (HTFL), Phoenix Education Partners, Inc. (PXED) and Veradermics, Incorporated (MANE)
- Stifel Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $40
- HeartFlow, Inc. (HTFL) Receives a New Rating From Freedom Capital Markets
- CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $37
- Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)
No comments yet — be the first to weigh in on HTFL.
Sign in to join the discussion.